348832 <common-name>N-[1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]nonadecanamide</common-name> <description>N-[1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]nonadecanamide is a chemical compound with the formula C28H49N3O6. With an average molecular weight of 523.70 g/mol, N-[1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]nonadecanamide is a heavy molecule.</description> <cas>59252-39-0</cas> <pubchem-id>42986</pubchem-id> <chemical-formula>C28H49N3O6</chemical-formula> <weight>523.7</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T13:01:37Z</created-at> <updated-at type="dateTime">2026-08-31T13:01:37Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)O</moldb-smiles> <moldb-formula>C28H49N3O6</moldb-formula> <moldb-inchi>InChI=1S/C28H49N3O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-24(33)29-23-19-20-31(28(36)30-23)27-26(35)25(34)22(21-32)37-27/h19-20,22,25-27,32,34-35H,2-18,21H2,1H3,(H,29,30,33,36)/t22-,25-,26+,27-/m1/s1</moldb-inchi> <moldb-inchikey>VXGYBQMZBBAOBJ-DRZCSJLFSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">523.3621363</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>7.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM344725</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[1-[(2r,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]nonadecanamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Nucleosides, nucleotides, and analogues</superklass> <klass>Pyrimidine nucleosides</klass> <subklass nil="true"/> <paper-count type="integer" nil="true"/> <sync-id>CED0299160</sync-id> <structure-inchikey>VXGYBQMZBBAOBJ-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>40000000108000000001000000000000000000000000020000000000000000020000200000000000000020000000000000000002000000000000000000000000000000400100022000000000208000004000000000000000000000000000200100000000000000000000000000000001000000000000000000001400000000404000000014000000000100800000800000000000002000004010000000000000000000000000000a0000000000000008000000000100000008200000000008000000000000000000000000000000000000020000000200080000000000008000000801000040010000010440400000000000000000000000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAA AAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIG AGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgAoAAAA AwQIACgAAAADAgcAaAAAAAMCAQZAKAAAAAMEB0AoAAAAAwMGQCgAAAADBAgA KAAAAAMCB0AoAAAAAwMGQGgAAAADAwEGQGgAAAADAwEGAGAAAAADAQYAYAAA AAMBBgBgAAAAAwEGAGAAAAADAQgAIAAAAAIGAGAAAAACAggAYAAAAAEBCABg AAAAAQEIAGAAAAABAQsAAQABAgACAwADBAAEBQAFBgAGBwAHCAAICQAJCgAK CwALDAAMDQANDgAODwAPEAAQEQAREgASEygCEhQgFBUgFRZoDBYXaAwXGCgC FxloDBkaaAwaG2gMGRwAHB0AHR4AHh8AHyAAHyEAISIAHiMAHSQAGxVoDCAc AEICAAAABhUbGhkXFgUdHCAfHhcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:47:05Z</structure-indexed-at> </compound>